Supportive Care in Cancer

, Volume 13, Issue 7, pp 554–558 | Cite as

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT—results of a randomized multicentre study

  • Samuel Vokurka
  • Eva Bystřická
  • Vladimír Koza
  • Jana Sčudlová
  • Vladislava Pavlicová
  • Dana Valentová
  • Jana Bocková
  • Lubica Mišaniová
Short Communication

Abstract

Antimicrobial solutions are widely used in the nursing care of chemotherapy induced oral mucositis (OM). There is little evidence, however, supporting their use for reducing mucosal damage. In our study, 132 patients were randomized to use normal saline (n=65) or povidone-iodine diluted 1:100 (n=67) mouthwashes for OM prophylaxis and treatment after high-dose chemotherapy comprising BEAM or HD-L-PAM followed by autologous peripheral stem cell transplantation. The study groups were well balanced in respect of age, sex, chemotherapy and the number of CD34+ cells in the graft. No significant difference was found between the groups in respect of OM characteristics, fever of unknown origin (FUO) and other infections. The antimicrobial solution was less tolerable for patients. OM occurred significantly more often in females than in males (86% vs 60%, P=0.0016) and was worse and of longer duration. The mechanical effect of mouthwashes might have a certain importance in FUO prevention. When indicating oral rinses, the patient’s individual preference and tolerance of solutions offered should be considered.

Keywords

Oral mucositis Povidone-iodine Mouthwashes Antimicrobial rinses Autologous transplantation Nursing 

References

  1. 1.
    Sonis S, Oster G, Fuchs H, et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205PubMedGoogle Scholar
  2. 2.
    Sezer O, Eucker J, Metzner B, et al (2000) Mucositis is associated with increased rate of documented infections and treatment related mortality after high-dose therapy with autologous peripheral stem-cell transplantation. Proc ASCO (abstract 216.)Google Scholar
  3. 3.
    Donnelly P, Bellm L, Epstein J, Sonis S, Symonds P (2003) Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 7:405–412Google Scholar
  4. 4.
    Ferreti GA, Raybould TP, Brown AT, et al (1990) Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomised double-blind trial. Oral Surg Oral Med Oral Pathol 69:331–338Google Scholar
  5. 5.
    Weisdorf DJ, Bostrom B, Raether D, et al (1989) Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant 4:89–95Google Scholar
  6. 6.
    Dodd MJ, Larson PJ, Dibble SL, et al (1996) Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 23:921–927Google Scholar
  7. 7.
    Samaranayake LP, Robertson AG, MacFarlane TW, et al (1988) The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 39:291–294Google Scholar
  8. 8.
    Lever SA, Dupuis LL, Chan HS (1987) Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intel Clin Pharm 21:359–361Google Scholar
  9. 9.
    Prada A, Chisea E (1987) Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tissue React 9:115–119Google Scholar
  10. 10.
    Rahn R, Adamietz IA, Boettcher HD, Schaefer V, Reimer K, Fleischer W (1997) Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 195 [Suppl 2]:57–61Google Scholar
  11. 11.
    Allison RR, Vongtama V, Vaughan J, Shin KH (1995) Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest 13:16–22Google Scholar
  12. 12.
    Okuno SH, Foote RL, Loprinzi CL, et al (1997) A randomized trial of nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 79:2193–2199Google Scholar
  13. 13.
    Wijers OB, Levendag PC, Harms ER, et al (2001) Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 50:343–352Google Scholar
  14. 14.
    Karthaus M, Rosental C, Ganser A (1999) Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis—are there new strategies? Bone Marrow Transplant 24:1095–1108Google Scholar
  15. 15.
    Sonis S, Elting L, Keefe D, et al (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100 [9 Suppl]:1995–2025Google Scholar
  16. 16.
    Robien K, Schubert M, Bruemmer B, et al (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplant for chronic myelogenous leukemia. J Clin Oncol 22:1268–1275Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Samuel Vokurka
    • 1
  • Eva Bystřická
    • 1
  • Vladimír Koza
    • 1
  • Jana Sčudlová
    • 2
  • Vladislava Pavlicová
    • 3
  • Dana Valentová
    • 4
  • Jana Bocková
    • 5
  • Lubica Mišaniová
    • 6
  1. 1.Department of Haemato-OncologyUniversity HospitalPilsenCzech Republic
  2. 2.Department of Haemato-OncologyUniversity Hospital OlomoucOlomoucCzech Republic
  3. 3.Department of Clinical HaematologyUniversity HospitalHradec KraloveCzech Republic
  4. 4.Department of Haematology and Transfusion MedicineUniversity HospitalBratislavaSlovak Republic
  5. 5.Department of HaematologyUniversity HospitalKosiceSlovak Republic
  6. 6.Department of HaematologyF.D.Roosevelt HospitalBanska BystricaSlovak Republic

Personalised recommendations